Versant Venture Management as of Sept. 30, 2015
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Glaukos (GKOS) | 43.6 | $76M | 3.1M | 24.19 | |
| Clovis Oncology | 21.5 | $38M | 407k | 91.96 | |
| Ocular Therapeutix (OCUL) | 17.9 | $31M | 2.2M | 14.06 | |
| Five Prime Therapeutics | 9.6 | $17M | 1.1M | 15.39 | |
| Achaogen | 4.2 | $7.4M | 1.3M | 5.76 | |
| Biotie Therapies Corp. ads | 2.0 | $3.5M | 269k | 13.09 | |
| Cymabay Therapeutics | 1.2 | $2.0M | 1.0M | 1.94 |
